Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
Get TradeMachine®
Get CML Research
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
4,180.77
+30.94
(
+0.74%
)
Dow 30
+0.78%
QQQ
+0.91%
VIX
21.26
+0.11
(
+0.52%
)
Arcutis Biotherapeutics Inc
NASDAQ:ARQT 10:28:24 AM EDT
25.00
-0.15
(
-0.60%
)
Products
Arcutis To Host Investor Conference Call Today To Discuss The FDA Approval Of Zoryve (Roflumilast) Cream 0.3% For Plaque Psoriasis
Published: 08/01/2022 14:33 GMT
ARQT
Arcutis Biotherapeutics Inc (
ARQT
)
- Arcutis to Host Investor Conference Call Today to Discuss the FDA Approval of Zoryve™ (roflumilast) Cream 0.3% for Plaque Psoriasis.